1.33 (-%)
As of Nov 01, 2024
Source:
We are a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. We view the immune system holistically and, rather than target one specific immune cell type, we focus on understanding biological pathways, the interactions of cells and the role each interaction plays in an immune response.
Country | United States |
Headquarters | beltsville, maryland |
Phone Number | 240-399-4900 |
Industry | manufacturing |
CEO | Michael Richman |
Website | www.nextcure.com |